Assessment of the tricuspid valve in hypoplastic left heart syndrome

Abstract

Hypoplastic left heart syndrome has provided the pediatric cardiology community one of its largest challenges. Until the mid-1980s, the mortality for this lesion was close to 100%. Through the pioneering work of Bill Norwood,1 Len Bailey,2 and the continued work of many pediatric cardiologists and surgeons, the current five-year survival for staged Norwood palliation and cardiac transplantation is now approximately 75%.3,4